Num | Author year | Design | NOS score | Surgery | Time after surgery | Number; | Age, years | BMD, g/cm2 (mean ± SD) |
---|---|---|---|---|---|---|---|---|
Gender | (mean ± SD) | |||||||
01 | Misra, M, 2020 [27] | Cohort study | 7 | SG | Over 12 months | 24, F/M | 17.80 ± 0.40 | ①②④ |
N | – | 24, F/M | 17.10 ± 0.50 | |||||
02 | Miriam A, 2020 [28] | Prospective study | 8 | SG | At 12 months | 26, F/M | 18.00 ± 2.10 | ③b⑥ |
N | – | 26, F/M | 17.00 ± 2.30 | |||||
03 | Madhusmita M, 2020 [26] | Cohort study | 6 | SG | Over 12 months | 22, F/M | 18.30 ± 2.35 | ①②③⑤ |
N | – | 21, F/M | 17.00 ± 2.35 | |||||
04 | Laurel L, 2019 [29] | Prospective study | 8 | RYGB | At 12 months | 24, F/M | 49.60 ± 1.40 | ③ |
DSE | – | 27, F/M | 47.40 ± 1.50 | |||||
05 | Masayuki Iki, 2019 [30] | Cohort study | 8 | G | 52.8 ± 13.2 (months) | 132, M | 74.6 ± 5.5 | ③ |
N | 51.6 ± 12 (months) | 1853, M | 72.9 ± 5.2 | |||||
06 | M R. Crawford, 2017 [31] | RCT | N | RYGB | At 12 months | 10, F/M | 50 ± 7 | ④a |
12–80.4 ± 15.6 months | ||||||||
At 80.4 ± 15.6 months | ||||||||
SG | At 12 months | 2, F/M | ||||||
12–80.4 ± 15.6 months | ||||||||
At 80.4 ± 15.6 months | ||||||||
IMT | At 12 months | 4, F/M | ||||||
12–80.4 ± 15.6 months | ||||||||
At 80.4 ± 15.6 months | ||||||||
07 | A H. Maghrabi, 2015 [33] | RCT | N | RYGB | At 12 months | 18, F/M | 48 ± 4 | ④a |
At 24 months | ||||||||
SG | At 12 months | 19, F/M | ||||||
At 24 months | ||||||||
IMT | At 12 months | 17, F/M | ||||||
At 24 months | ||||||||
08 | Menegati, G C, 2015 [32] | Cohort study | 7 | RYGB | 6–64 months | 25, M | 38.90 ± 7.39 | ①③ |
DSE | – | 33, M | 38.90 ± 7.39 | |||||
09 | T. L. Costa, 2014 [35] | Cohort study | 7 | BS | 33.3 ± 15.8 months | 56, F/M | 36.4 ± 8.5 | ①③ |
N | – | 27, F/M | 36.9 ± 9.6 | |||||
10 | Renata, 2010 [37] | Cohort study | 7 | BS | – | 15, M | 35.07 ± 7.36 | ①③ |
N | – | 14, M | 34.71 ± 8.09 | |||||
11 | Juan P, 2009 [38] | Cohort study | 6 | RYGB | 12–60 months | 26, M | 58.00 ± 3.90 | ①③ |
N | – | 26, M | 57.50 ± 4.70 | |||||
12 | Gómez, J. M, 2019 [39] | Cohort study | 7 | RYGB | Over 12 months | 41, M | 46 ± 9.2 | ⑤ |
N | – | 25, M | 48 ± 7.6 | |||||
13 | de la Maza, M. P, 2008 [40] | Cohort study | 7 | RYGB | over 18 months | 33, M | 44.42 ± 8.87 | ①③ |
N | – | 29, M | 41.76 ± 8.87 | |||||
14 | Pereira, F. A, 2007 [41] | Cohort study | 8 | RYGB | 9.8 ± 1.9 months | 16, M | 37.80 ± 6.80 | ①③⑥ |
N | – | 11, M | 37.20 ± 10.25 | |||||
N | – | 12, M | 32.40 ± 0.03 | |||||
15 | Goode, L. R, 2004 [42] | Cohort study | 8 | RYGB | 48 ± 12 months | 23, M | 41.00 ± 5.00 | ①③ |
RYGB | 48 ± 12 months | 21, M | 54.00 ± 7.00 | |||||
N | – | 23, M | 43.00 ± 6.00 | |||||
N | – | 21 + 21, M | 55.00 ± 7.00 | |||||
16 | Coates, P. S, 2004 [43] | Cohort study | 8 | LRGB | 10.8 ± 2.6 months | 25, F/M | 51.00 ± 8.00 | ⑥ |
N | – | 30, F/M | 49.00 ± 10.00 | |||||
17 | Guney, 2003 [44] | Cohort study | 8 | VBG | At 12 months | 16, F/M | 34.18 ± 7.72 | ①②③ |
N | – | 65, F/M | 42.00 ± 5.42 | |||||
18, F/M | 58.2 ± 18.2 (F) | ①③ | ||||||
18 | Heiskanen, J. T, 2001 [45] | Retrospective study | 7 | G | 71 ± 20 months | 61.6 ± 10.1 (M) | ||
46, F/M | 57.5 ± 14.0 (F) | |||||||
N | – | 59.4 ± 4.6 (M) | ||||||
19 | Inoue, K, 1992 [47] | Retrospective study | 7 | G | 24–60 months | 34, M | 50–69 | ③ |
G | 72–120 months | 11, M | ||||||
N | – | 115, M | ||||||
20 | Hintze, L. J, 2014 [34] | Retrospective study | 7 | BS | ≤ 16 months | 20, M | 36.85 ± 26.5 | ①③⑤ |
17–36 months | 12, M | 45.8 ± 10.18 | ||||||
over 37 months | 8, M | 51.75 ± 12.15 | ||||||
N | – | 21, M | 43.40 ± 15.70 | |||||
21 | Yu, E. W, 2013 [36] | Prospective study | 8 | BS | At 12 months | 30, F/M | 47 ± 14 | ②a④a |
N | – | 19, F/M | 46 ± 16 | |||||
22 | Ott, M. T, 1992 [46] | Retrospective study | 7 | RYGB | 120 months | 26, F | 45 | â‘ |
N | – | 7, F | 46 |